The markets traded higher during the midday with the Dow rising 34 points to 18,131 after the European Central Bank lifted its eurozone growth forecast from 1% to 1.5%. Nasdaq added 12 points to 4,979.
On the upside
The Food and Drug Administration released briefing documents for Kythera Biopharma's (Nasdaq: KYTH) ATX-101 indicating a favorable benefit-risk assessment.
Vivint Solar (NYSE: VSLR) reported a smaller than expected loss for the fourth quarter.
Geron (Nasdaq: GERN) narrowed losses for the fourth quarter.
On the downside
Capnia (Nasdaq: CAPN) closed a transaction for Series B warrant holders to exercise their warrants and issued new Series C warrants.
Eclipse Resources (NYSE: ECR) widened losses for the fourth quarter.
Momo (Nasdaq: MOMO) widened fourth quarter losses.
In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 4 on the NYSE and by more than 3 to 2 on Nasdaq. The broader S&P 500 added a point to 2099. Bitcoin slipped $5 to $264.
Markets higher as ECB lifts eurozone growth forecast
March 05, 2015 at 12:30 PM EST